Open Access

Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis

Corrigendum in: /10.3892/ijmm.2023.5267

  • Authors:
    • Xiaoqiang Liu
    • Yanlong Wu
    • Zhengtao Zhou
    • Mingchuan Huang
    • Wen Deng
    • Yibing Wang
    • Xiaochen Zhou
    • Luyao Chen
    • Yu Li
    • Tao Zeng
    • Gongxian Wang
    • Bin Fu
  • View Affiliations

  • Published online on: June 12, 2019     https://doi.org/10.3892/ijmm.2019.4241
  • Pages: 683-693
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Celecoxib, a selective cyclooxygenase‑2 inhibitor, has chemo‑preventive activity against different cancer types, including bladder cancer (BC). However, the mechanisms by which celecoxib exerts its cancer preventative effects have yet to be completely understood. In the present study, the effect of celecoxib on the epithelial‑to‑mesenchymal transition (EMT) of BC cells and its potential molecular mechanisms were investigated. The results of the present study demonstrated that celecoxib inhibited the proliferation, migration, invasion and EMT of BC cells. Further investigation of the underlying mechanism revealed that celecoxib inhibited EMT by upregulating microRNA (miR)‑145 and downregulating the expression of transforming growth factor β receptor 2 and SMAD family member 3. Furthermore, the combination of celecoxib with miR‑145 mimics demonstrated an additive migration and invasion‑inhibitory effect in BC cell lines.
View Figures
View References

Related Articles

Journal Cover

August-2019
Volume 44 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu X, Wu Y, Zhou Z, Huang M, Deng W, Wang Y, Zhou X, Chen L, Li Y, Zeng T, Zeng T, et al: Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis Corrigendum in /10.3892/ijmm.2023.5267. Int J Mol Med 44: 683-693, 2019
APA
Liu, X., Wu, Y., Zhou, Z., Huang, M., Deng, W., Wang, Y. ... Fu, B. (2019). Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis Corrigendum in /10.3892/ijmm.2023.5267. International Journal of Molecular Medicine, 44, 683-693. https://doi.org/10.3892/ijmm.2019.4241
MLA
Liu, X., Wu, Y., Zhou, Z., Huang, M., Deng, W., Wang, Y., Zhou, X., Chen, L., Li, Y., Zeng, T., Wang, G., Fu, B."Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis Corrigendum in /10.3892/ijmm.2023.5267". International Journal of Molecular Medicine 44.2 (2019): 683-693.
Chicago
Liu, X., Wu, Y., Zhou, Z., Huang, M., Deng, W., Wang, Y., Zhou, X., Chen, L., Li, Y., Zeng, T., Wang, G., Fu, B."Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis Corrigendum in /10.3892/ijmm.2023.5267". International Journal of Molecular Medicine 44, no. 2 (2019): 683-693. https://doi.org/10.3892/ijmm.2019.4241